Ormeloxifene treatment inhibits growth of cisplatin-resistant ovarian cancer cells

被引：0
|
作者：
Nordquist, Jordan [1 ,2 ]
Maher, Diane M. [1 ]
Ebeling, Mara [1 ]
Jaggi, Meena [1 ,3 ,4 ]
Chauhan, Subhash C. [1 ,3 ,4 ]
机构：
[1] Sanford Res USD, Canc Biol Res Ctr, Sioux Falls, SD USA
[2] Univ S Dakota, Sanford Sch Med, Sioux Falls, SD USA
[3] Univ S Dakota, Sanford Sch Med, Dept OB GYN, Sioux Falls, SD USA
[4] Univ S Dakota, Sanford Sch Med, Basic Biomed Sci Div, Sioux Falls, SD USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-4521
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4521
引用
收藏
页数：1
相关论文
共 50 条
  • [1] MicroRNA-18a targeting inhibits the tumor growth of cisplatin-resistant ovarian cancer
    Iris Quinones-Diaz, Blanca
    Reyes-Gonzalez, Jeyshka M.
    Valiyeva, Fatma
    Vivas-Mejia, Pablo E.
    CANCER RESEARCH, 2020, 80 (16)
  • [2] Ormeloxifene efficiently inhibits ovarian cancer growth
    Maher, Diane M.
    Khan, Sheema
    Nordquist, Jordan L.
    Ebeling, Mara C.
    Bauer, Nichole A.
    Kopel, Lucas
    Singh, Man Mohan
    Halaweish, Fathi
    Bell, Maria C.
    Jaggi, Meena
    Chauhan, Subhash C.
    CANCER LETTERS, 2015, 356 (02) : 606 - 612
  • [3] Gemcitabine in cisplatin-resistant ovarian cancer
    Lund, B
    Neijt, JP
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 72 - 76
  • [4] HOTAIR is a potential target for the treatment of cisplatin-resistant ovarian cancer
    Wang, Yu
    Wang, Hongli
    Song, Tiefang
    Zou, Yiting
    Jiang, Jing
    Fang, Lei
    Li, Peiling
    MOLECULAR MEDICINE REPORTS, 2015, 12 (02) : 2211 - 2216
  • [5] Valproic acid resensitizes cisplatin-resistant ovarian cancer cells
    Lin, Ching-Tai
    Lai, Hung-Cheng
    Lee, Hsin-Yi
    Lin, Wei-Hsin
    Chang, Cheng-Chang
    Chu, Tang-Yuan
    Lin, Ya-Wen
    Lee, Kuan-Der
    Yu, Mu-Hsien
    CANCER SCIENCE, 2008, 99 (06): : 1218 - 1226
  • [6] Systemic mesenchymal stem cells reduce growth rate of cisplatin-resistant ovarian cancer
    Zhu, Pengfei
    Chen, Mo
    Wang, Li
    Ning, Yanxia
    Liang, Jie
    Zhang, Hao
    Xu, Congjian
    Chen, Sifeng
    Yao, Liangqing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (11): : 2506 - 2514
  • [7] Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer
    Reyes-Gonzalez, Jeyshka M.
    Armaiz, Guillermo N.
    Mangala, Lingegowda S.
    Valiyeva, Fatma
    Pradeep, Sunila
    Sood, Anil K.
    Vivas-Mejia, Pablo E.
    CANCER RESEARCH, 2014, 74 (19)
  • [8] THE ISOLATION AND CHARACTERIZATION OF CISPLATIN-RESISTANT RAT OVARIAN-CANCER CELLS
    SEKIYA, S
    OOSAKI, T
    ANDOH, S
    SUZUKI, N
    NAGAO, K
    TAKAMIZAWA, H
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (05): : 851 - +
  • [9] Dacomitinib improves chemosensitivity of cisplatin-resistant human ovarian cancer cells
    Xu, Lei
    Xu, Ying
    Zheng, Jianbing
    Zhao, Yun
    Wang, Hongcai
    Qi, Yushu
    ONCOLOGY LETTERS, 2021, 22 (01)
  • [10] Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer
    Reyes-Gonzalez, Jeyshka M.
    Quinones-Diaz, Blanca I.
    Santana, Yasmarie
    Baez-Vega, Perla M.
    Soto, Daniel
    Valiyeva, Fatima
    Marcos-Martinez, Maria J.
    Fernandez-de Thomas, Ricardo J.
    Vivas-Mejia, Pablo E.
    CANCERS, 2020, 12 (04)
12345